Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Murakami

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Journal of Alzheimer'S Disease : JAD|May 12, 2011
Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's diseaseKazuma Murakami, Nakaba Murata, Yusuke Ozawa, et al.
Bioscience, Biotechnology, and Biochemistry|November 13, 2010
Silymarin attenuated the amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer's disease mouse modelNakaba Murata, Kazuma Murakami, Yusuke Ozawa, et al.
Bioscience, Biotechnology, and Biochemistry|June 11, 2013
Inhibition of amyloid β aggregation by acteoside, a phenylethanoid glycosideManami Kurisu, Yusaku Miyamae, Kazuma Murakami, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2012
Preparation of stable amyloid β-protein oligomers of defined assembly orderClark Rosensweig, Kenjiro Ono, Kazuma Murakami, et al.
ACS Omega|September 9, 2020
Detection of Amyloid β Oligomers with RNA Aptamers in App<sup>NL-G-F/NL-G-F</sup> Mice: A Model of Arctic Alzheimer's DiseaseYayoi Obata, Kazuma Murakami, Taiji Kawase, et al.
Journal of the American Chemical Society|October 27, 2005
Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's diseaseKazuma Murakami, Kazuhiro Irie, Hajime Ohigashi, et al.
Bioorganic & Medicinal Chemistry|August 28, 2012
Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-proteinYusaku Miyamae, Manami Kurisu, Kazuma Murakami, et al.
ACS Chemical Neuroscience|September 29, 2012
Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42Naotaka Izuo, Toshiaki Kume, Mizuho Sato, et al.
Biochemical and Biophysical Research Communications|May 10, 2011
Insulin receptor mutation results in insulin resistance and hyperinsulinemia but does not exacerbate Alzheimer's-like phenotypes in miceKazuma Murakami, Shin-ichi Yokoyama, Nakaba Murata, et al.
The Journal of Biological Chemistry|August 29, 2003
Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's diseaseKazuma Murakami, Kazuhiro Irie, Akira Morimoto, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Journal of Alzheimer'S Disease : JAD|May 12, 2011
Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's diseaseKazuma Murakami, Nakaba Murata, Yusuke Ozawa, et al.
Bioscience, Biotechnology, and Biochemistry|November 13, 2010
Silymarin attenuated the amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer's disease mouse modelNakaba Murata, Kazuma Murakami, Yusuke Ozawa, et al.
Bioscience, Biotechnology, and Biochemistry|June 11, 2013
Inhibition of amyloid β aggregation by acteoside, a phenylethanoid glycosideManami Kurisu, Yusaku Miyamae, Kazuma Murakami, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2012
Preparation of stable amyloid β-protein oligomers of defined assembly orderClark Rosensweig, Kenjiro Ono, Kazuma Murakami, et al.
ACS Omega|September 9, 2020
Detection of Amyloid β Oligomers with RNA Aptamers in App<sup>NL-G-F/NL-G-F</sup> Mice: A Model of Arctic Alzheimer's DiseaseYayoi Obata, Kazuma Murakami, Taiji Kawase, et al.
Journal of the American Chemical Society|October 27, 2005
Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's diseaseKazuma Murakami, Kazuhiro Irie, Hajime Ohigashi, et al.
Bioorganic & Medicinal Chemistry|August 28, 2012
Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-proteinYusaku Miyamae, Manami Kurisu, Kazuma Murakami, et al.
ACS Chemical Neuroscience|September 29, 2012
Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42Naotaka Izuo, Toshiaki Kume, Mizuho Sato, et al.
Biochemical and Biophysical Research Communications|May 10, 2011
Insulin receptor mutation results in insulin resistance and hyperinsulinemia but does not exacerbate Alzheimer's-like phenotypes in miceKazuma Murakami, Shin-ichi Yokoyama, Nakaba Murata, et al.
The Journal of Biological Chemistry|August 29, 2003
Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's diseaseKazuma Murakami, Kazuhiro Irie, Akira Morimoto, et al.
Pageof 9